BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL)
BetterInvesting Magazine's Editorial Advisory and Securities Review Committee has named Merck (MRK) as its 'Stock to Study' and Ball Corp (BALL) as its 'Undervalued Stock' in the January 2025 issue. The announcement aims to provide educational resources for investors. The organization has launched a free eLearning course called Stock Investing Basics to help new investors get started. The committee emphasizes these selections are for educational purposes only and not explicit purchase recommendations.
Il Comitato Consultivo Editoriale e di Revisione dei Titoli di BetterInvesting Magazine ha nominato Merck (MRK) come 'Titolo da Studiare' e Ball Corp (BALL) come 'Titolo Sottovalutato' nel numero di gennaio 2025. L'annuncio ha lo scopo di fornire risorse educative per gli investitori. L'organizzazione ha lanciato un corso di eLearning gratuito chiamato Fondamenti dell'Investimento in Azioni per aiutare i nuovi investitori a iniziare. Il comitato sottolinea che queste selezioni sono solo per scopi educativi e non raccomandazioni esplicite all'acquisto.
El Comité Asesor Editorial y de Revisión de Valores de BetterInvesting Magazine ha nombrado a Merck (MRK) como 'Acción para Estudiar' y a Ball Corp (BALL) como 'Acción Subvaluada' en el número de enero de 2025. El anuncio tiene como objetivo proporcionar recursos educativos para los inversores. La organización ha lanzado un curso gratuito de eLearning llamado Conceptos Básicos de Inversión en Acciones para ayudar a los nuevos inversores a empezar. El comité enfatiza que estas selecciones son solo con fines educativos y no recomendaciones de compra explícitas.
BetterInvesting 매거진의 편집 자문위원회 및 증권 리뷰 위원회는 Merck (MRK)를 '연구할 주식'으로, Ball Corp (BALL)을 '저평가된 주식'으로 선정하였습니다. 이 발표는 투자자들을 위한 교육 자료를 제공하기 위한 것입니다. 이 조직은 '주식 투자 기초'라는 무료 eLearning 과정을 시작하여 신규 투자자들이 시작할 수 있도록 돕고 있습니다. 위원회는 이러한 선정이 교육 목적만을 위한 것이며 구체적인 구매 추천이 아님을 강조합니다.
Le Comité Consultatif Éditorial et le Comité de Révision des Titres de BetterInvesting Magazine ont désigné Merck (MRK) comme 'Action à Étudier' et Ball Corp (BALL) comme 'Action Sous-Évaluée' dans le numéro de janvier 2025. L'annonce vise à fournir des ressources éducatives pour les investisseurs. L'organisation a lancé un cours eLearning gratuit intitulé Notions de Base de l'Investissement en Actions pour aider les nouveaux investisseurs à débuter. Le comité souligne que ces sélections sont uniquement à des fins éducatives et ne constituent pas des recommandations d'achat explicites.
Der Editorial Advisory and Securities Review Committee von BetterInvesting Magazine hat Merck (MRK) als 'Aktie zum Studieren' und Ball Corp (BALL) als 'Unterbewertete Aktie' in der Januarausgabe 2025 benannt. Die Ankündigung zielt darauf ab, Bildungsressourcen für Investoren bereitzustellen. Die Organisation hat einen kostenlosen eLearning-Kurs mit dem Titel Grundlagen der Aktienanlage gestartet, um neuen Investoren den Einstieg zu erleichtern. Das Komitee betont, dass diese Auswahl nur zu Bildungszwecken dient und keine ausdrücklichen Kaufempfehlungen sind.
- Ball Corp (BALL) identified as an undervalued stock by BetterInvesting's expert committee
- None.
The organization remains concerned about the number of Americans who are investing for the future. "Too many Americans hesitate to invest, waiting for what they believe is the perfect moment, such as after the election, or for other reasons, missing out on the benefits of compounding. With Halloween less than a week away, it's a reminder that those who take part, reap the rewards," said Ken Zendel, CEO of the National Association of Investors (NAIC), the parent organization of BetterInvesting.
To help investors get started, the National Association of Investors has launched a free eLearning course entitled Stock Investing Basics available for anyone who desires to learn at https://www.betterinvesting.org/learn-about-investing/elearning-courses
Explore the January 2025 issue of BetterInvesting Magazine for more education as well as details about the latest stocks recommended for study by the Editorial Advisory and Securities Review Committee. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of both Merck & Co. as well as Ball Corp. by viewing their fundamental data and applying judgments.
Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.
About BetterInvesting:
BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org
Follow us on LinkedIn, Instagram and Facebook.
Contact: 877-275-6242
View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-merck-mrk-and-ball-ball-302287661.html
SOURCE NAIC-BetterInvesting
FAQ
Why was Ball Corp (BALL) selected as BetterInvesting's undervalued stock for January 2025?